FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2605872007> ?p ?o ?g. }

• W2605872007 abstract "This meta-analysis of data from 14 phase 2 and 3, double-blind, randomized, controlled 12- and 24-week studies (N = 4632) summarizes saxagliptin efficacy in patients with type 2 diabetes (T2D) across treatment regimens.Patients received saxagliptin 5 mg/d or control as either monotherapy (n = 1196 vs placebo), add-on therapy (n = 2139 vs placebo and n = 514 vs uptitrated sulfonylurea), or initial combination therapy (n = 619 vs control monotherapy). Patients with renal impairment received saxagliptin 2.5 mg/d or placebo (n = 164).Mean baseline glycated hemoglobin (A1C) ranged from 8.07% to 9.43% for the saxagliptin and control groups across treatment regimens. A1C reduction from baseline was greater with saxagliptin versus control for all studies combined (mean treatment difference [95% CI]: -0.55% [-0.63%, -0.47%]) and when used as monotherapy (-0.52% [-0.63, -0.40%]), add-on (-0.55% [-0.69%, -0.40%] vs placebo; -0.72% [-0.88%, -0.56%] vs uptitrated sulfonylurea), initial combination therapy (-0.54% [-0.73%, -0.35%] vs control monotherapy), and in patients with renal impairment (-0.42% [-0.75%, -0.09%]). Similar reductions in A1C versus control were noted for patients <65 years (-0.55% [-0.67%, -0.43%]) and ≥65 years (-0.54% [-0.69%, -0.38%]) and for men (-0.54% [-0.69%, -0.40%]) and women (-0.55% [-0.64%, -0.47%]) across treatment regimens. More patients achieved A1C <7% (39% vs 23%) and A1C ≤6.5% (24% vs 14%) with saxagliptin than with placebo or active-control treatment. Saxagliptin versus control was associated with a reduction in glucagon area under the curve (AUC) from baseline and increases in insulin AUC, C-peptide AUC, and the homeostasis model assessment of β-cell function.Results of this meta-analysis demonstrate the consistency of saxagliptin efficacy in different subgroups of patients with T2D across treatment regimens.AstraZeneca." @default.
• W2605872007 created "2017-04-28" @default.
• W2605872007 creator A5010861180 @default.
• W2605872007 creator A5024617569 @default.
• W2605872007 creator A5030399648 @default.
• W2605872007 creator A5044528603 @default.
• W2605872007 creator A5046617394 @default.
• W2605872007 creator A5062793550 @default.
• W2605872007 creator A5072950568 @default.
• W2605872007 date "2017-04-21" @default.
• W2605872007 modified "2023-10-08" @default.
• W2605872007 title "Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials" @default.
• W2605872007 cites W1486033897 @default.
• W2605872007 cites W1548863206 @default.
• W2605872007 cites W1605983684 @default.
• W2605872007 cites W1963542379 @default.
• W2605872007 cites W1970125713 @default.
• W2605872007 cites W1971471384 @default.
• W2605872007 cites W1982202068 @default.
• W2605872007 cites W1993472763 @default.
• W2605872007 cites W2006247067 @default.
• W2605872007 cites W2007221722 @default.
• W2605872007 cites W2009999012 @default.
• W2605872007 cites W2025791731 @default.
• W2605872007 cites W2031195667 @default.
• W2605872007 cites W2032322539 @default.
• W2605872007 cites W2033331104 @default.
• W2605872007 cites W2037434990 @default.
• W2605872007 cites W2045063167 @default.
• W2605872007 cites W2045321591 @default.
• W2605872007 cites W2045923887 @default.
• W2605872007 cites W2048728983 @default.
• W2605872007 cites W2054564814 @default.
• W2605872007 cites W2059623316 @default.
• W2605872007 cites W2064130493 @default.
• W2605872007 cites W2073229674 @default.
• W2605872007 cites W2079644358 @default.
• W2605872007 cites W2103058881 @default.
• W2605872007 cites W2104239190 @default.
• W2605872007 cites W2104763836 @default.
• W2605872007 cites W2109728760 @default.
• W2605872007 cites W2116492775 @default.
• W2605872007 cites W2126065052 @default.
• W2605872007 cites W2127854619 @default.
• W2605872007 cites W2128050336 @default.
• W2605872007 cites W2139923324 @default.
• W2605872007 cites W2142830692 @default.
• W2605872007 cites W2144325462 @default.
• W2605872007 cites W2146264128 @default.
• W2605872007 cites W2150483909 @default.
• W2605872007 cites W2153552938 @default.
• W2605872007 cites W2157891776 @default.
• W2605872007 cites W2161852973 @default.
• W2605872007 cites W2164282118 @default.
• W2605872007 cites W2171294019 @default.
• W2605872007 cites W2193379135 @default.
• W2605872007 cites W2196906371 @default.
• W2605872007 cites W2282578582 @default.
• W2605872007 cites W2302447233 @default.
• W2605872007 cites W2337454357 @default.
• W2605872007 cites W2425644022 @default.
• W2605872007 cites W2519510391 @default.
• W2605872007 cites W4231460044 @default.
• W2605872007 cites W4239088940 @default.
• W2605872007 doi "https://doi.org/10.1007/s13300-017-0261-8" @default.
• W2605872007 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5446386" @default.
• W2605872007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28432619" @default.
• W2605872007 hasPublicationYear "2017" @default.
• W2605872007 type Work @default.
• W2605872007 sameAs 2605872007 @default.
• W2605872007 citedByCount "8" @default.
• W2605872007 countsByYear W26058720072017 @default.
• W2605872007 countsByYear W26058720072018 @default.
• W2605872007 countsByYear W26058720072019 @default.
• W2605872007 countsByYear W26058720072020 @default.
• W2605872007 crossrefType "journal-article" @default.
• W2605872007 hasAuthorship W2605872007A5010861180 @default.
• W2605872007 hasAuthorship W2605872007A5024617569 @default.
• W2605872007 hasAuthorship W2605872007A5030399648 @default.
• W2605872007 hasAuthorship W2605872007A5044528603 @default.
• W2605872007 hasAuthorship W2605872007A5046617394 @default.
• W2605872007 hasAuthorship W2605872007A5062793550 @default.
• W2605872007 hasAuthorship W2605872007A5072950568 @default.
• W2605872007 hasBestOaLocation W26058720071 @default.
• W2605872007 hasConcept C126322002 @default.
• W2605872007 hasConcept C134018914 @default.
• W2605872007 hasConcept C142724271 @default.
• W2605872007 hasConcept C204787440 @default.
• W2605872007 hasConcept C27081682 @default.
• W2605872007 hasConcept C2776999253 @default.
• W2605872007 hasConcept C2777180221 @default.
• W2605872007 hasConcept C2777538456 @default.
• W2605872007 hasConcept C2778854520 @default.
• W2605872007 hasConcept C2779284873 @default.
• W2605872007 hasConcept C2779306644 @default.
• W2605872007 hasConcept C2780282729 @default.
• W2605872007 hasConcept C555293320 @default.
• W2605872007 hasConcept C71924100 @default.
• W2605872007 hasConcept C90924648 @default.
• W2605872007 hasConceptScore W2605872007C126322002 @default.

• next